Share purchase by incoming Director (incoming CEO)

Summary by AI ^BETAClose X

Victrex plc announced that incoming Chief Executive Officer, Dr James Routh, voluntarily purchased 4,520 ordinary shares in the company on December 5, 2025, through two transactions at prices of 663.5775p and 666.0734p per share, bringing his total holding to 4,520 shares.

Disclaimer*

Victrex PLC

05 December 2025

5 December 2025

Victrex plc

Share purchase by incoming Director (incoming CEO)

Victrex plc (the 'Company') announces that Dr James Routh, who joins Victrex as Chief Executive Officer on 1 January 2026, has notified the Company that he has purchased a total of 4,520 ordinary shares in the Company on 5 December 2025 in two transactions as follows:

- 3,026 shares at a price of 663.5775p

- 1,494 shares at a price of 666.0734p

This share purchase disclosure is made voluntarily as James has not yet assumed the role of director.

Following this transaction, Dr James Routh holds 4,520 ordinary shares in the Company.

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy & industrial, electronics and medical. Every day, millions of people use products and applications which contain our sustainable materials - from smartphones, aeroplanes and cars to energy production and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, enable environmental and societal benefits, and drive value for our shareholders. Find out more at www.victrexplc.com.

Victrex plc:

Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG +44 (0) 7809 595831

Registered Office: Victrex Technology Centre, Hillhouse International

Thornton Cleveleys, Lancashire, FY5 4QD

Registered Number: 2793780, England and Wales

LEI number: 213800UYNPHAUNHPXL67

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END